- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Finalisation of commercial agreement with Croda
- Holding(s) in Company
- Integration update and share price movement
- Issue of Equity and Total Voting Rights
- Acquisition and Financial Update
- Notice of Investor Meet Company Presentation
- Final testing of SkinBiotix by Croda completed
- Investment of £1.56m from new investors
- Appointment of Senior Croda VP as Board Advisor
- Full year trading update
More ▼
Key statistics
As of last trade SkinBioTherapeutics PLC (SBTX:LSE) traded at 16.07, -19.25% below its 52-week high of 19.90, set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.88 |
---|---|
High | 16.07 |
Low | 16.00 |
Bid | 15.75 |
Offer | 16.25 |
Previous close | 15.88 |
Average volume | 1.18m |
---|---|
Shares outstanding | 228.44m |
Free float | 184.29m |
P/E (TTM) | -- |
Market cap | 36.26m GBP |
EPS (TTM) | -0.0165 GBP |
Data delayed at least 20 minutes, as of Nov 22 2024 14:22 GMT.
More ▼